Join Now

Category Archives: BioUtah News

Myriad Genetics Named to Fast Company’s Annual List of World’s Most Innovative Companies

By Natalie Themm | Published March 17, 2022

Myriad to establish new Walter Gilbert Research and Innovation Center Company also cited among 2022 Top Workplaces USA National List by Energage

| Tagged | Leave a comment

Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer

By Natalie Themm | Published March 17, 2022

BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer

| Tagged | Leave a comment

Myriad Genetics Advances Precision Oncology with New Precise™ Solutions, Combines Genetic Insights from Multiple Tests to Guide Treatment Decisions and Improve Patient Care

By Natalie Themm | Published March 17, 2022

Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution

| Tagged | Leave a comment

Pfizer Completes Acquisition of Arena Pharmaceuticals

By Natalie Themm | Published March 17, 2022

Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases

| Tagged | Leave a comment

PolarityTE Announces $5.0 Million Registered Direct Offering

By Natalie Themm | Published March 16, 2022

PolarityTE Announces $5.0 Million Registered Direct Offering

| Tagged | Leave a comment

Senate HELP Committee Advances PREVENTS Pandemic Act

By Natalie Themm | Published March 16, 2022

The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act.

Also posted in Policy News | | Leave a comment

Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase Program

By Natalie Themm | Published March 15, 2022

Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock.

| Tagged , | Leave a comment

Tillis, Coons, Cotton, Hirono, and Scott Introduce Bipartisan Bill to Prevent the Chinese Communist Party from Stealing American Intellectual Property

By Natalie Themm | Published March 15, 2022

Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts.

| Leave a comment

2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit is a Raging Success

By Denise Bell | Published March 10, 2022

The 2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit presented by BioUtah, BioHive and the PIVOT Center attracted a record setting 300+ registrants along with an impressive line-up of distinguished speakers, national and local investors and numerous Utah life sciences startups. Now in its 7th year, the Summit (our first in person since COVID-19) […]

| Leave a comment

Xenter Selects New Headquarters in Draper

By Natalie Themm | Published March 10, 2022

Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah.

| Tagged | Leave a comment

Renalytix Launches myIntelX, Providing National Physician Access to KidneyIntelX Testing Platform

By Natalie Themm | Published March 9, 2022

myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners

| Tagged | Leave a comment

IONIQ Sciences announces IP acquisition and License buyout

By Natalie Themm | Published March 9, 2022

IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance.

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members